Tag: Michael Nevradakis

Citing ‘Orwellian’ Tactics, Federal Judge Orders White House to Stop Censoring Americans’ Social Media Posts

James Fetzerblog

By Michael Nevradakis, Ph.D. In his 155-page ruling, Judge Terry Doughty said there is “substantial evidence” the government violated the First Amendment by engaging in a large-scale censorship campaign targeting content that questioned or countered establishment narratives on COVID-19. In a landmark ruling Tuesday, a federal judge temporarily barred several Biden administration officials and federal agencies from communicating with social media platforms. In his 155-page ruling, Judge Terry Doughty of the U.S. District Court for the Western District of Louisiana Monroe Division said there is “substantial evidence” the government violated the…

As Monkeypox Cases Spread, Report Shows Gates Foundation, WHO, Pharma Execs Took Part in Monkeypox Pandemic ‘Simulation’

James Fetzerblog

Michael Nevradakis, Ph.D. The World Health Organization on Friday held an emergency meeting to discuss the outbreak of monkeypox after more than 100 cases were reported across 12 countries, as a report surfaced showing the Gates Foundation, WHO and Pharma execs in March 2021 conducted a monkeypox pandemic “simulation.” The World Health Organization (WHO) on Friday held an emergency meeting to discuss the outbreak of monkeypox after more than 100 cases were reported across 12 countries. Days before the WHO convened, the Biden administration placed a $119 million order for monkeypox vaccines after the Centers for…

Pfizer Steps Up Advertising for Its ‘Blockbuster’ Drug to Treat Heart Conditions, Including Those Caused by COVID Vaccines

James Fetzerblog

By Michael Nevradakis, Ph.D. Pfizer and Bristol Myers Squibb this month revived the “No Time to Wait” ad campaign urging people experiencing heart issues to visit their doctors. The two drugmakers developed and market Eliquis, the top-selling drug for the very heart conditions associated with people who received Pfizer’s COVID vaccine. Two major pharmaceutical companies chose February, the month of love — or hearts — to launch an advertising campaign urging people experiencing heart issues for the first time to visit their doctors. Pfizer and Bristol Myers Squibb (BMS) this month revived the “No…